BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 2011;91:885-95. [PMID: 21423135 DOI: 10.1038/labinvest.2011.44] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Spruss A, Henkel J, Kanuri G, Blank D, Püschel GP, Bischoff SC, Bergheim I. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med. 2012;18:1346-1355. [PMID: 22952059 DOI: 10.2119/molmed.2012.00223] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
2 Brandt A, Jin CJ, Nolte K, Sellmann C, Engstler AJ, Bergheim I. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment. Nutrients 2017;9:E1013. [PMID: 28906444 DOI: 10.3390/nu9091013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
3 Alwahsh SM, Gebhardt R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch Toxicol. 2017;91:1545-1563. [PMID: 27995280 DOI: 10.1007/s00204-016-1892-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 12.5] [Reference Citation Analysis]
4 Dornas WC, de Lima WG, Pedrosa ML, Silva ME. Health implications of high-fructose intake and current research. Adv Nutr 2015;6:729-37. [PMID: 26567197 DOI: 10.3945/an.114.008144] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 7.9] [Reference Citation Analysis]
5 Nier A, Brandt A, Conzelmann IB, Özel Y, Bergheim I. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern. Nutrients 2018;10:E1329. [PMID: 30235828 DOI: 10.3390/nu10091329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
6 Campbell PT, VanWagner LB, Colangelo LA, Lewis CE, Henkel A, Ajmera VH, Lloyd-Jones DM, Vaughan DE, Khan SS. Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. Liver Int 2020;40:1111-20. [PMID: 32090434 DOI: 10.1111/liv.14417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hege M, Jung F, Sellmann C, Jin C, Ziegenhardt D, Hellerbrand C, Bergheim I. An iso-α-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice. Nutrition 2018;45:68-75. [PMID: 29129239 DOI: 10.1016/j.nut.2017.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wagnerberger S, Fiederlein L, Kanuri G, Stahl C, Millonig G, Mueller S, Bischoff SC, Bergheim I. Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice. Alcohol Alcohol. 2013;48:648-656. [PMID: 23969550 DOI: 10.1093/alcalc/agt138] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
9 Mathew J, Huang SC, Dumolt JH, Patel MS, Rideout TC. Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny. Reproduction 2020;160:1-10. [PMID: 32272447 DOI: 10.1530/REP-20-0065] [Reference Citation Analysis]
10 Volynets V, Machann J, Küper MA, Maier IB, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52:527-535. [PMID: 22543623 DOI: 10.1007/s00394-012-0355-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
11 Nier A, Brandt A, Rajcic D, Bruns T, Bergheim I. Short-Term Isocaloric Intake of a Fructose- but not Glucose-Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects. Mol Nutr Food Res 2019;63:e1800868. [PMID: 30570214 DOI: 10.1002/mnfr.201800868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Holzberg JR, Jin R, Le NA, Ziegler TR, Brunt EM, McClain CJ, Konomi JV, Arteel GE, Vos MB. Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. J Pediatr Gastroenterol Nutr 2016;62:819-23. [PMID: 26704864 DOI: 10.1097/MPG.0000000000001096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
13 Cho IJ, Oh DH, Yoo J, Hwang YC, Ahn KJ, Chung HY, Jeong SW, Moon JY, Lee SH, Lim SJ, Jeong IK. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. Sci Rep 2021;11:9894. [PMID: 33972568 DOI: 10.1038/s41598-021-88872-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li L, Fang B, Zhang Y, Yan L, He Y, Hu L, Xu Q, Li Q, Dai X, Kuang Q, Xu M, Tan J, Ge C. Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction. Biomed Pharmacother 2021;145:112404. [PMID: 34781143 DOI: 10.1016/j.biopha.2021.112404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Nicolás-Toledo L, Cervantes-Rodríguez M, Cuevas-Romero E, Corona-Quintanilla DL, Pérez-Sánchez E, Zambrano E, Castelán F, Rodríguez-Antolín J. Hitting a triple in the non-alcoholic fatty liver disease field: sucrose intake in adulthood increases fat content in the female but not in the male rat offspring of dams fed a gestational low-protein diet. J Dev Orig Health Dis 2018;9:151-9. [PMID: 29249214 DOI: 10.1017/S204017441700099X] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest. 2012;92:1020-1032. [PMID: 22525431 DOI: 10.1038/labinvest.2012.75] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 10.1] [Reference Citation Analysis]
17 Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. Liver Int. 2015;35:562-568. [PMID: 24351080 DOI: 10.1111/liv.12442] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
18 Brandt A, Rajcic D, Jin CJ, Sánchez V, Engstler AJ, Jung F, Nier A, Baumann A, Bergheim I. Fortifying diet with rapeseed oil instead of butterfat attenuates the progression of diet-induced non-alcoholic fatty liver disease (NAFLD) and impairment of glucose tolerance. Metabolism 2020;109:154283. [DOI: 10.1016/j.metabol.2020.154283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Jin R, Frediani JK, Holzberg J, Vos MB. Role of PAI-1 in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. Curr Cardiovasc Risk Rep 2017;11. [DOI: 10.1007/s12170-017-0536-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Silbernagel G, Machann J, Häring H, Fritsche A, Peter A. Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur J Clin Nutr 2014;68:97-100. [DOI: 10.1038/ejcn.2013.228] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
21 Jin R, Krasinskas A, Le N, Konomi JV, Holzberg J, Romero R, Vos MB. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease: PAI-1 and pediatric NAFLD. Pediatric Obesity 2018;13:23-9. [DOI: 10.1111/ijpo.12183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
22 Sellmann C, Jin CJ, Degen C, De Bandt J, Bergheim I. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. The Journal of Nutrition 2015;145:2280-6. [DOI: 10.3945/jn.115.215517] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
23 Castro MC, Massa ML, Arbeláez LG, Schinella G, Gagliardino JJ, Francini F. Fructose-induced inflammation, insulin resistance and oxidative stress: A liver pathological triad effectively disrupted by lipoic acid. Life Sciences 2015;137:1-6. [DOI: 10.1016/j.lfs.2015.07.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
24 Lee SM, Dorotea D, Jung I, Nakabayashi T, Miyata T, Ha H. TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease. Oncotarget 2017;8:89746-60. [PMID: 29163785 DOI: 10.18632/oncotarget.21120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
25 Chiu S, Sievenpiper JL, de Souza RJ, Cozma AI, Mirrahimi A, Carleton AJ, Ha V, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Don-Wauchope AC, Beyene J, Kendall CW, Jenkins DJ. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68:416-423. [PMID: 24569542 DOI: 10.1038/ejcn.2014.8] [Cited by in Crossref: 172] [Cited by in F6Publishing: 151] [Article Influence: 21.5] [Reference Citation Analysis]
26 Qiu L, Lin J, Xu F, Gao Y, Zhang C, Liu Y, Luo Y, Yang JY. Inhibition of aldose reductase activates hepatic peroxisome proliferator-activated receptor-α and ameliorates hepatosteatosis in diabetic db/db mice. Exp Diabetes Res 2012;2012:789730. [PMID: 22110479 DOI: 10.1155/2012/789730] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
27 Narasimhan A, Chinnaiyan M, Karundevi B. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat. Appl Physiol Nutr Metab 2015;40:769-81. [PMID: 26201855 DOI: 10.1139/apnm-2015-0002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
28 Laguna JC, Alegret M, Roglans N. Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients 2014;6:5933-54. [PMID: 25533006 DOI: 10.3390/nu6125933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
29 Morinaga M, Kon K, Saito H, Arai K, Kusama H, Uchiyama A, Yamashina S, Ikejima K, Watanabe S. Sodium 4-phenylbutyrate prevents murine dietary steatohepatitis caused by trans-fatty acid plus fructose. J Clin Biochem Nutr. 2015;57:183-191. [PMID: 26566303 DOI: 10.3164/jcbn.15-75] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
30 Savari F, Mard SA, Badavi M, Rezaie A, Gharib-Naseri MK. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterol 2019;19:125. [PMID: 31307427 DOI: 10.1186/s12876-019-1041-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
31 Nier A, Engstler AJ, Maier IB, Bergheim I. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. PLoS One 2017;12:e0183282. [PMID: 28880885 DOI: 10.1371/journal.pone.0183282] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
32 Tappy L, Mittendorfer B. Fructose toxicity: is the science ready for public health actions? Curr Opin Clin Nutr Metab Care 2012;15:357-61. [PMID: 22617566 DOI: 10.1097/MCO.0b013e328354727e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
33 Lembede BW, Erlwanger KH, Nkomozepi P, Chivandi E. Terminalia Sericea aqueous leaf extract protects growing wistar rats against fructose-induced fatty liver disease. J Complement Integr Med 2018;16. [PMID: 29927747 DOI: 10.1515/jcim-2018-0035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Landmann M, Kanuri G, Spruss A, Stahl C, Bergheim I. Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice. Nutrition 2014;30:882-9. [DOI: 10.1016/j.nut.2013.11.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
35 Engstler AJ, Frahnow T, Kruse M, Pfeiffer AFH, Bergheim I. Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins. Twin Res Hum Genet 2017;20:338-48. [DOI: 10.1017/thg.2017.36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
36 Tappy L, Lê KA. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin Res Hepatol Gastroenterol 2012;36:554-60. [PMID: 22795319 DOI: 10.1016/j.clinre.2012.06.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]